No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
314 |
4. Check minimum number of eventsNone |
314 |
5. Include endpointsNone |
314 |
6. Filter based on genotype QC (FinnGen only) |
281 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Ductal carcinoma of pancreas
based on the number of shared cases.
Similar with more cases:
- Adenocarcinoma and ductal carcinoma of pancreas
- Malignant neoplasm of pancreas
- Malignant neoplasm of pancreas, including Hilmo
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, including Hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 281 | 127 | 154 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 69.39 | 69.83 | 69.04 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 290
- Matched controls
- 2900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
391.7
307.7
190
14
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
423.5
307.7
179
11
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
211.7
307.7
161
17
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
252
*
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
268.6
307.7
192
21
Z51.5
ICD-10 Finland
Palliative care
66.9
274.3
171
61
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
257.1
207
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
100.1
245.4
132
24
A03FA01
ATC
metoclopramide; systemic, rectal
45.2
244.9
223
199
8500/3-C25.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of pancreas, NOS
+∞
193.0
163
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3158.7
175.9
152
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
172.7
148
*
A04AA02
ATC
granisetron; systemic, transdermal
2869.3
166.6
145
*
JN4AD
NOMESCO Finland
Body CT examination
25.8
163.6
139
100
N02AA05
ATC
oxycodone; systemic
21.8
163.0
202
276
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
151.8
132
*
L01BC06
ATC
capecitabine; oral
+∞
140.3
123
*
JAH01
NOMESCO Finland
Laparoscopy
36.0
136.6
92
37
TPX10
NOMESCO Finland
Implantation of vascular injection port
81.0
134.7
73
12
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
27.7
132.5
100
54
A04AA01
ATC
ondansetron; systemic, rectal
34.1
115.5
78
31
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
114.3
102
*
R4190
NOMESCO Finland
Nutritional therapy
38.9
110.5
71
24
UJK02
NOMESCO Finland
ERCP
32.3
109.3
75
31
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
73.8
107.6
59
10
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
19.1
103.0
92
69
8500/3-C25.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of head of pancreas
+∞
102.3
92
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
41.8
96.3
60
18
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
86.9
79
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
28.3
86.0
61
27
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1002.5
80.4
75
*
JN4BD
NOMESCO Finland
Extensive body CT
15.8
79.7
77
65
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
78.8
72
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
157.0
78.6
80
7
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
44.2
73.9
45
12
JN4CD
NOMESCO Finland
Very extensive body CT
31.8
71.4
48
18
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
10.7
69.6
91
119
WZC00
NOMESCO Finland
Treatment plan or consultation
7.9
69.5
183
516
K83.1
ICD-10 Finland
Obstruction of bile duct
103.7
66.6
71
9
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
62.8
58
*
TPH07
NOMESCO Finland
Cathetrisation of artery
8.1
59.2
102
183
R50.9
ICD-10 Finland
Fever, unspecified
7.5
57.4
109
216
JN3AD
NOMESCO Finland
Abdominal CT examination
7.5
55.4
102
195
B01AB10
ATC
tinzaparin; parenteral
8.4
54.3
85
136
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
53.9
50
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
25.6
52.6
38
17
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
88.1
52.3
57
8
L03AA02
ATC
filgrastim; parenteral
+∞
51.6
48
*
WZC30
NOMESCO Finland
Teaching
6.8
50.4
102
213
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
154.0
49.6
51
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.1
47.3
87
164
A04AA55
ATC
palonosetron, combinations; systemic
+∞
43.9
41
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
92.7
43.4
47
6
WW500
NOMESCO Finland
Blood transfusion
18.8
42.5
35
21
B01AB05
ATC
enoxaparin; parenteral
5.0
41.7
162
583
B01AB04
ATC
dalteparin; parenteral
11.3
41.5
47
49
WX402
NOMESCO Finland
General anaesthesia
5.2
39.6
117
336
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
39.5
37
*
A06AH03
ATC
naloxegol; oral
118.9
38.8
41
*
XX3DW
NOMESCO Finland
Time consuming IT work
10.0
38.1
47
55
L03AA13
ATC
pegfilgrastim; parenteral
217.7
37.8
38
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
37.3
35
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
37.3
35
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
37.3
35
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
12.0
36.6
39
37
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.9
36.4
113
335
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
+∞
36.2
34
*
A10AB05
ATC
insulin aspart; parenteral
6.5
35.9
68
130
PHN73
NOMESCO Finland
Reconstruction of superior mesenteric or portal vein
+∞
35.1
33
*
ZX120
NOMESCO Finland
Intravenous
7.5
34.3
55
88
D76
ICPC
Malignant neoplasm pancreas
+∞
34.0
32
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.0
33.4
69
143
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
58.4
31.1
36
7
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.2
31.1
77
187
JLC10
NOMESCO Finland
Distal pancreatectomy
+∞
29.7
28
*
TPH04
NOMESCO Finland
Cathetrisation of vein
4.1
28.7
113
391
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
28.6
27
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
8.1
26.5
38
53
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
29.4
25.5
34
13
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
26.3
25.5
35
15
K83.0
ICD-10 Finland
Cholangitis
38.3
24.8
31
9
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
24.3
23
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
260.6
24.0
24
*
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
136.3
24.0
25
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
28.7
23.2
31
12
A10AE04
ATC
insulin glargine; parenteral
4.5
22.5
65
176
A04AD12
ATC
aprepitant; systemic
+∞
22.2
21
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
22.2
21
*
A02BC02
ATC
pantoprazole; systemic
5.2
22.1
254
1675
WX892
NOMESCO Finland
Monitored bed care
5.0
21.4
52
122
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
20.4
195
1115
C25
ICD-10 Finland
Malignant neoplasm of pancreas
+∞
20.0
19
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.5
19.8
91
338
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
214.0
19.8
20
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
107.1
18.8
20
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
107.1
18.8
20
*
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
+∞
17.9
17
*
Z31.5
ICD-10 Finland
Genetic counselling
8.4
17.7
24
31
8500/3-C25.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of body of pancreas
+∞
16.8
16
*
8500/3-C25.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of tail of pancreas
+∞
16.8
16
*
115
Kela drug reimbursment
Breast cancer
+∞
16.8
16
*
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
+∞
16.8
16
*
WF002
NOMESCO Finland
Radical radiotherapy
95.7
16.8
18
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
16.3
95
402
R18
ICD-10 Finland
Ascites
12.8
15.9
28
24
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
12.8
15.9
28
24
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
40.5
15.6
19
5
ZXE40
NOMESCO Finland
More than seven and less than nine hours
19.1
15.4
23
13
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
47.7
15.2
18
*
1CD01, ,
NOMESCO Finland
+∞
14.7
14
*
ZX122
NOMESCO Finland
Intra-arterial
+∞
14.7
14
*
A79
ICPC
Malignancy NOS
+∞
14.7
14
*
J01MA12
ATC
levofloxacin; systemic
3.1
14.7
79
317
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
23.7
14.4
20
9
JAH00
NOMESCO Finland
Laparotomy
11.8
14.3
26
24
N02AX02
ATC
tramadol; systemic, rectal
2.6
14.3
163
957
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
44.9
14.3
17
*
N05BA06
ATC
lorazepam; systemic, sublingual
4.8
14.2
34
78
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.1
13.8
72
283
R4110
NOMESCO Finland
Physiotherapy
2.7
13.7
103
492
103
Kela drug reimbursment
Diabetes, insulin-treated
2.6
13.7
125
657
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
13.8
13.7
23
18
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
36.0
13.7
17
5
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
+∞
13.6
13
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
146.6
13.6
14
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.9
13.3
25
46
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.0
12.6
23
41
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
135.6
12.5
13
*
WX725
NOMESCO Finland
Noninvasive ventilation
4.4
12.5
33
82
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.5
12.4
115
603
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
11.8
12.3
22
20
WX704
NOMESCO Finland
Intubation
4.1
12.1
36
98
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
48.8
12.0
14
*
C10AC01
ATC
colestyramine; oral
5.9
11.8
22
40
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
9.9
11.7
23
25
WX004
NOMESCO Finland
Patient-controlled sedation
67.8
11.7
13
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
11.5
11
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
+∞
11.5
11
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
124.8
11.5
12
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
11.5
118
644
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
11.3
54
200
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
26.2
11.3
15
6
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
8.8
11.0
23
28
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
29.3
10.8
14
5
D70.82
ICD-10 Finland
Drug-induced neutropenia
62.4
10.7
12
*
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
+∞
10.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.5
10
*
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
+∞
10.5
10
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
10.5
10
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
10.5
10
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
10.5
10
*
K85.8
ICD-10 Finland
Other acute pancreatitis
24.4
10.3
14
6
WX610
NOMESCO Finland
Patient controlled analgesia
41.6
10.0
12
*
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
27.1
9.9
13
5
SPAT1109
SPAT
Analgesia with portable analgesic pump
56.9
9.7
11
*
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
5.2
9.5
20
41
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
9.4
9
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
9.4
9
*
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
+∞
9.4
9
*
191
Kela drug reimbursment
Erlotinib
+∞
9.4
9
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.5
9.3
23
54
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
9.3
51
204
WW200, ,
SPAT
0.3
8.7
33
809
J01MA02
ATC
ciprofloxacin; systemic
2.1
8.7
133
832
WX002
NOMESCO Finland
Sedation and analgesia
2.4
8.7
74
366
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
8.6
111
650
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.1
8.5
20
30
L02BG04
ATC
letrozole; oral
92.6
8.5
9
*
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
92.6
8.5
9
*
L02BA01
ATC
tamoxifen; oral
92.6
8.5
9
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.0
8.4
17
20
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
9.3
8.1
16
18
WPA13
NOMESCO Finland
Palliative consultation
34.4
8.1
10
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.6
8.1
18
25
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
8.1
46
187
N05AD01
ATC
haloperidol; systemic
4.7
8.0
19
43
HA1AA
NOMESCO Finland
X-ray mammography
4.9
8.0
18
39
R11
ICD-10 Finland
Nausea and vomiting
3.0
8.0
38
140
A06AD11
ATC
lactulose; oral
2.4
7.8
58
269
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
46.2
7.8
9
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
46.2
7.8
9
*
SPAT1262
SPAT
Handing over of treatment supplies
2.3
7.6
66
327
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
82.1
7.5
8
*
TPX15
NOMESCO Finland
Removal of vascular injection port
82.1
7.5
8
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
7.3
58
276
ZX121
NOMESCO Finland
Central venous catheter
+∞
7.3
7
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
+∞
7.3
7
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
PHN72
NOMESCO Finland
Plastic repair of superior mesenteric or portal vein
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
7.3
7
*
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
12.5
7.1
12
10
A41.8
ICD-10 Finland
Other specified sepsis
6.6
7.1
17
27
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.6
7.1
17
27
SPAT1255
SPAT
Intravenous administration of medicine
3.2
6.9
28
94
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
11.3
6.9
12
11
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
41.0
6.8
8
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
41.0
6.8
8
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
23.1
6.7
9
*
C10AA07
ATC
rosuvastatin; oral
0.4
6.6
46
886
C10AA05
ATC
atorvastatin; oral
0.5
6.6
71
1166
E0000UV, ,
ATC
1.9
6.6
128
851
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.9
6.5
19
51
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
71.4
6.5
7
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
71.4
6.5
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
71.4
6.5
7
*
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
71.4
6.5
7
*
TJA10
NOMESCO Finland
Laparocentesis
+∞
6.3
6
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
6.3
6
*
C25.7
ICD-10 Finland
Malignant neoplasm: Other parts of pancreas
+∞
6.3
6
*
JDE01
NOMESCO Finland
Laparoscopic gastroenterostomy
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
6.3
6
*
325
Kela drug reimbursment
Erlotinib
+∞
6.3
6
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
27.3
6.3
8
*
WX882
NOMESCO Finland
High dependency care
5.6
6.3
17
32
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
6.2
38
160
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.8
6.1
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
245
143
104.97
307.65
10.2
1.4
13.93
2.67
ug/l
2.12
239
112
162
62
57.93
252.93
11.3
1.8
2024.59
93.17
u/ml
1.16
154
48
154
62
51.83
235.42
1.6
1.3
95.89
301.33
ug/g
9.86
79
37
51
11
56.04
88.39
1.3
1.1
—
—
—
0
0
43
12
41.90
69.71
1.5
1.6
3.20
4.28
nmol/l
0.34
43
12
232
849
9.66
66.59
7.7
2.2
95.66
64.53
u/l
0.87
226
785
112
226
7.44
58.04
9.6
2.1
372.60
35.41
u/l
0.59
100
184
145
392
6.40
55.16
13.4
6.1
104.95
104.20
mmol/l
1.27
145
392
253
1302
8.39
41.96
16.1
14.9
1.20
1.28
inr
2.45
212
1082
115
339
4.96
37.39
12.9
7.6
1.24
1.20
mmol/l
0.04
108
285
220
1096
5.17
35.09
4.8
2.4
—
—
estimate
—
0
0
243
1326
6.14
34.06
38.3
5.9
3.96
4.29
e9/l
1.70
219
1152
108
326
4.69
33.63
2.2
1.8
—
—
—
0
0
74
164
5.72
33.28
1.7
1.6
—
—
—
0
0
129
451
4.35
32.97
2.2
1.8
—
—
—
0
0
111
352
4.49
32.25
2.3
1.8
—
—
—
0
0
110
376
4.10
28.36
2.1
2.4
15.92
23.49
%
8.97
110
350
177
845
3.81
27.58
13.2
2.1
2.30
2.35
mmol/l
5.13
171
736
118
440
3.84
26.58
2.3
2.4
9.00
13.10
umol/l
10.49
118
407
216
1200
4.14
26.26
12.2
5.8
1.17
1.21
mmol/l
8.85
208
1089
110
423
3.58
23.16
2.2
1.8
30.06
29.44
s
0.55
110
410
224
1345
3.92
22.65
12.6
6.3
1.17
1.21
mmol/l
10.01
198
1173
124
572
3.04
18.57
3.8
2.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
73
5.66
18.43
3.4
2.5
0.21
0.44
iu/ml
4.14
19
41
33
69
5.27
15.37
2.0
1.6
—
—
—
0
0
48
148
3.69
13.57
1.8
1.4
—
—
—
0
0
147
839
2.53
13.46
3.8
3.1
26.46
108.61
e6/l
0.53
113
629
130
718
2.47
12.56
3.8
2.9
0.77
0.41
e6/l
0.54
96
508
25
53
5.07
11.41
1.2
1.2
—
—
—
0
0
25
56
4.79
10.71
1.2
1.2
—
—
—
0
0
23
30
8.23
10.61
1.3
1.3
—
—
—
0
0
12
5
24.93
8.98
1.7
1.2
75.25
59.40
nmol/l
—
12
5
26
71
3.92
8.66
1.1
1.3
—
—
—
0
0
115
688
2.11
8.41
2.2
2.3
3.03
2.89
mg/l
0.25
107
583
216
2516
0.45
7.66
4.0
5.7
1.36
1.46
mmol/l
2.88
197
2304
218
2528
0.45
7.52
4.2
5.8
4.27
4.49
mmol/l
2.30
202
2331
225
2571
0.44
7.10
4.8
6.7
2.48
2.57
mmol/l
0.75
207
2365
41
168
2.68
7.06
2.0
1.6
—
—
—
0
0
18
34
5.57
6.58
1.1
1.3
—
—
—
0
0
40
169
2.59
6.47
2.2
2.3
0.80
0.60
%
1.88
40
169
76
425
2.07
6.40
3.6
2.9
2.89
2.29
e6/l
0.15
31
201
6
0
+∞
6.27
1.7
0.0
25.98
—
u/ml
—
6
0
39
173
2.45
5.70
2.2
2.3
1.38
1.16
%
0.50
39
173
78
458
1.96
5.67
3.5
2.7
1.49
1.04
e6/l
0.42
36
233
15
28
5.59
5.61
1.1
1.2
—
—
—
0
0
19
57
3.50
5.54
1.3
1.2
—
—
—
0
0
13
24
5.62
4.97
1.1
1.3
—
—
—
0
0
17
51
3.48
4.96
1.4
1.2
—
—
—
0
0
211
2415
0.54
4.96
3.7
4.8
1.33
1.28
mmol/l
0.45
192
2195
9
10
9.24
4.82
1.2
1.2
—
—
—
0
0
204
2352
0.55
4.77
4.2
5.3
1.96
2.02
mu/l
0.32
186
2138
55
304
2.00
4.69
3.5
3.0
2.45
1.93
mmol/l
0.51
49
264
15
43
3.62
4.68
1.4
1.2
—
—
—
0
0
149
1115
1.69
4.63
2.6
2.9
218.87
141.01
ug/l
1.82
144
1031
7
5
14.29
4.60
1.1
3.8
3.71
9.20
ug/l
—
7
5
226
2524
0.53
4.57
5.1
5.7
6.55
6.08
mmol/l
5.05
220
2298
86
562
1.75
4.33
4.6
4.4
104.07
396.79
ng/l
1.70
76
473
10
17
6.05
4.16
1.1
1.4
—
—
—
0
0
81
1161
0.58
4.14
2.0
2.0
1.32
1.30
mmol/l
0.06
72
969
23
497
0.42
4.13
1.2
1.3
48.50
36.80
iu/ml
—
5
148
105
743
1.65
3.88
4.5
4.0
0.00
0.01
estimate
0.50
33
233
10
19
5.41
3.86
1.0
1.0
—
—
—
0
0
15
379
0.36
3.85
3.7
5.5
33.90
32.25
%
—
10
233
11
26
4.35
3.54
1.3
1.3
—
—
—
0
0
12
33
3.75
3.33
1.2
1.1
—
—
—
0
0
16
62
2.67
3.10
1.1
1.3
—
—
—
0
0
165
1937
0.66
3.05
3.6
4.2
15.15
14.94
pmol/l
0.52
149
1753
221
2429
0.62
2.84
52.2
14.2
83.70
76.08
ml/min/173m2
7.65
214
2258
165
1363
1.49
2.79
4.5
3.9
0.00
0.02
estimate
0.65
38
237
24
442
0.50
2.74
1.2
1.3
2.32
12.65
u/ml
—
6
154
160
1326
1.46
2.59
4.5
3.9
0.00
0.00
estimate
-0.00
38
251
13
51
2.62
2.48
1.4
1.2
—
—
—
0
0
161
1347
1.44
2.41
4.5
3.9
0.00
0.00
estimate
-0.00
40
256
8
204
0.37
2.39
1.1
2.3
6.65
3.41
ratio
—
8
170
5
9
5.63
2.22
1.8
2.6
—
—
—
0
0
14
61
2.36
2.18
6.0
3.2
1.89
1.26
index
—
9
34
14
62
2.32
2.11
1.3
1.5
—
—
—
0
0
11
44
2.56
2.03
1.5
1.4
—
—
—
0
0
11
44
2.56
2.03
1.5
1.4
—
—
—
0
0
138
1152
1.38
1.95
4.4
4.1
23.66
111.02
ng/l
0.99
113
878
45
640
0.65
1.93
2.3
3.0
0.79
0.73
ug/l
0.14
30
428
38
248
1.61
1.88
6.8
3.2
—
—
—
0
0
8
28
2.91
1.87
1.0
1.0
—
—
—
0
0
6
18
3.38
1.75
1.0
1.1
—
—
—
0
0
6
18
3.38
1.75
1.0
1.1
—
—
—
0
0
6
18
3.38
1.75
1.0
1.1
—
—
—
0
0
5
13
3.89
1.72
10.6
1.8
0.20
1.15
index
—
5
13
81
631
1.39
1.71
4.3
4.2
1.02
1.02
kg/l
0.80
59
427
10
40
2.55
1.68
1.0
1.0
1.90
1.52
g/l
—
10
34
15
76
2.03
1.67
1.5
1.2
—
—
—
0
0
8
171
0.45
1.64
1.1
1.4
—
41.81
—
0
17
121
1010
1.34
1.64
5.0
3.9
0.00
0.01
estimate
0.50
34
201
5
15
3.37
1.53
1.0
1.2
—
—
—
0
0
32
212
1.57
1.51
2.7
2.2
77.48
63.20
ml/min/173m2
—
10
79
236
2491
0.72
1.34
8.1
7.3
43.47
40.09
mmol/mol
4.62
228
2327
5
118
0.41
1.28
2.6
2.5
35.40
40.54
u/l
—
5
100
5
114
0.43
1.15
1.0
1.2
4.82
3.74
g/l
—
5
98
5
114
0.43
1.15
1.0
1.2
4.58
4.34
g/l
—
5
98
5
114
0.43
1.15
1.0
1.2
7.88
7.40
g/l
—
5
98
8
40
2.03
1.13
1.9
2.6
106.00
105.32
mmol/l
—
8
40
103
879
1.27
1.11
1.8
1.7
22.41
19.93
nmol/l
1.13
98
734
69
563
1.30
1.06
1.4
1.7
3.93
1.04
mg/l
1.43
64
437
7
34
2.08
1.03
1.4
1.4
—
—
—
0
0
16
99
1.65
1.02
2.3
3.2
—
—
—
0
0
59
719
0.77
0.97
2.3
2.4
330.46
358.60
umol/l
0.86
54
616
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
5
105
0.47
0.90
1.0
1.4
—
—
—
0
0
6
29
2.09
0.90
1.8
1.0
—
—
—
0
0
60
493
1.27
0.88
1.7
1.8
1436.29
1185.19
nmol/l
1.21
51
372
6
30
2.02
0.87
1.8
1.0
—
—
—
0
0
81
695
1.23
0.82
4.5
3.5
0.00
0.00
estimate
-0.00
31
198
100
1128
0.83
0.80
4.0
4.4
2.18
1.93
ug/l
0.44
91
1007
18
254
0.69
0.77
1.2
1.5
—
—
—
0
0
14
91
1.57
0.76
1.5
1.5
—
—
—
0
0
9
54
1.69
0.75
1.0
1.2
—
—
—
0
0
5
24
2.10
0.75
1.0
1.1
—
—
—
0
0
7
39
1.81
0.73
2.0
2.6
1.21
1.19
mmol/l
—
7
39
5
26
1.94
0.71
1.0
1.1
—
—
—
0
0
99
1106
0.84
0.69
4.3
4.1
8.13
8.81
mg/mmol
0.08
66
683
69
593
1.21
0.69
1.9
1.8
403.63
32238634.97
pmol/l
0.69
60
487
5
27
1.87
0.68
1.6
2.1
—
—
—
0
0
14
95
1.50
0.65
1.5
1.5
—
—
—
0
0
5
30
1.68
0.61
2.0
1.0
—
—
—
0
0
8
51
1.58
0.61
1.0
1.3
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.3
—
158.50
—
0
23
137
1269
1.15
0.55
3.1
2.4
—
—
—
0
0
82
909
0.86
0.51
4.5
4.1
20.14
24.27
%
1.84
37
434
13
93
1.42
0.49
1.3
1.4
—
—
—
0
0
10
69
1.47
0.45
1.1
1.2
—
—
—
0
0
5
32
1.57
0.42
2.0
1.0
—
—
—
0
0
5
32
1.57
0.42
2.0
1.4
—
—
—
0
0
5
32
1.57
0.42
2.0
1.0
—
—
—
0
0
5
32
1.57
0.42
2.0
1.0
—
—
—
0
0
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
1.03
—
0
9
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
9
69
1.31
0.37
1.1
1.2
—
—
—
0
0
5
80
0.62
0.36
1.2
1.3
—
—
—
0
0
10
74
1.36
0.32
1.5
1.8
—
—
—
0
0
40
360
1.13
0.25
24.2
7.3
—
—
—
0
0
6
82
0.73
0.24
1.8
1.4
0.25
0.22
g/l
—
6
77
6
84
0.71
0.24
1.8
1.4
1.08
1.17
g/l
—
6
79
103
978
1.08
0.23
2.2
3.3
1407.27
1201.74
ng/l
0.18
95
835
5
41
1.22
0.22
1.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
1861.30
—
0
10
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
5.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
259.33
—
0
6
0
13
0.00
0.21
0.0
1.4
—
64.71
—
0
13
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
49
1.23
0.20
3.2
5.2
49.33
27.37
mg/l
—
6
39
25
276
0.90
0.16
1.5
1.4
—
—
—
0
0
89
927
0.94
0.15
1.9
2.2
168.36
272.28
u/l
0.58
81
867
127
1308
0.95
0.15
2.2
2.2
89.41
97.02
pmol/l
1.28
98
665
56
532
1.07
0.13
1.3
1.3
8.28
1.38
u/ml
0.46
17
140
122
1189
1.05
0.11
2.7
2.4
63.71
78.48
nmol/l
6.65
116
1042
19
173
1.11
0.10
2.1
3.7
1.98
2.42
mmol/l
—
10
124
190
1927
0.96
0.10
3.0
4.6
18.35
11.93
mm/h
5.00
177
1781
5
46
1.09
0.09
1.4
1.4
217.80
290.58
pmol/l
—
5
38
5
47
1.06
0.09
6.2
2.9
15.06
11.05
pmol/l
—
5
47
6
54
1.11
0.09
1.2
1.3
—
—
—
0
0
23
246
0.93
0.08
1.2
1.4
—
—
—
0
0
7
67
1.05
0.08
1.3
1.5
—
—
—
0
0
13
139
0.93
0.03
4.8
3.3
1.02
1.02
ratio
0.31
13
129
11
109
1.01
0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.17
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
53
0.94
-0.00
1.0
1.1
—
5.50
—
0
6
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
26
260
1.00
-0.00
1.3
1.8
1.41
1.64
%
0.92
20
217
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
9.73
—
0
9
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PANCREAS_DUCTAL – Ductal carcinoma of pancreas
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).